The Duke Glioma Handbook: Pathology, Diagnosis, and Management
Immunotherapy for gliomas
Publication
, Chapter
Fecci, PE; Riccione, K; Dunn, GP; Reap, E; Vlahovic, G; Congdon, K; Sampson, JH
March 31, 2016
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Fecci, P. E., Riccione, K., Dunn, G. P., Reap, E., Vlahovic, G., Congdon, K., & Sampson, J. H. (2016). Immunotherapy for gliomas. In The Duke Glioma Handbook: Pathology, Diagnosis, and Management (pp. 91–120). https://doi.org/10.1017/CBO9781107588721.006
Fecci, P. E., K. Riccione, G. P. Dunn, E. Reap, G. Vlahovic, K. Congdon, and J. H. Sampson. “Immunotherapy for gliomas.” In The Duke Glioma Handbook: Pathology, Diagnosis, and Management, 91–120, 2016. https://doi.org/10.1017/CBO9781107588721.006.
Fecci PE, Riccione K, Dunn GP, Reap E, Vlahovic G, Congdon K, et al. Immunotherapy for gliomas. In: The Duke Glioma Handbook: Pathology, Diagnosis, and Management. 2016. p. 91–120.
Fecci, P. E., et al. “Immunotherapy for gliomas.” The Duke Glioma Handbook: Pathology, Diagnosis, and Management, 2016, pp. 91–120. Scopus, doi:10.1017/CBO9781107588721.006.
Fecci PE, Riccione K, Dunn GP, Reap E, Vlahovic G, Congdon K, Sampson JH. Immunotherapy for gliomas. The Duke Glioma Handbook: Pathology, Diagnosis, and Management. 2016. p. 91–120.